Aberrant methylation of tissue factor pathway inhibitor-2 is a biomarker for HSIL and squamous cell carcinoma of the cervix

被引：0
|
作者：
Bin Yang [1 ]
Ji, Xin [1 ]
Scheidemantel, Thomas [1 ]
Abu Shahin, Fadi [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
CANCER CYTOPATHOLOGY | 2007年 / 111卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PF7
引用
收藏
页码：349 / 350
页数：2
相关论文
共 50 条
  • [21] Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue
    Wojtukiewicz, MZ
    Sierko, E
    Zimnoch, L
    Kozlowski, L
    Kisiel, W
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (01) : 140 - 146
  • [22] Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas
    Nobeyama, Yoshimasa
    Okochi-Takada, Eriko
    Furuta, Junichi
    Miyagi, Yohei
    Kikuchi, Kanako
    Yamamoto, Akifumi
    Nakanishi, Yukihiro
    Nakagawa, Hidemi
    Ushijima, Toshikazu
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (02) : 301 - 307
  • [23] Tissue factor pathway inhibitor-2 is a new acute phase reactant
    Hisaka, T
    Lamireau, T
    Maurel, P
    Kisiel, W
    Desmoulire, A
    Rosenbaum, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 74 - 74
  • [24] Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2
    Iino, M
    Foster, DC
    Kisiel, W
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (01) : 40 - 46
  • [25] Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis
    Herman, MP
    Sukhova, GK
    Kisiel, W
    Foster, D
    Kehry, MR
    Libby, P
    Schönbeck, U
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09): : 1117 - 1126
  • [26] Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
    Ota, Yukihide
    Koizume, Shiro
    Nakamura, Yoshiyasu
    Yoshihara, Mitsuyo
    Takahashi, Tomoko
    Sato, Shinya
    Myoba, Shohei
    Ohtake, Norihisa
    Kato, Hisamori
    Yokose, Tomoyuki
    Miyagi, Etsuko
    Miyagi, Yohei
    ONCOLOGY REPORTS, 2021, 45 (03) : 1023 - 1032
  • [27] Tissue factor pathway inhibitor-2:: A novel inhibitor of matrix metalloproteinases with implications for atherosclerosis
    Herman, MP
    Sukhova, GK
    Foster, D
    Kisiel, W
    Schönbeck, U
    CIRCULATION, 2000, 102 (18) : 173 - 174
  • [28] Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study
    Kawaguchi, Ryuji
    Maehana, Tomoka
    Sugimoto, Sumire
    Kawahara, Naoki
    Iwai, Kana
    Yamada, Yuki
    Kimura, Fuminori
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (01) : 25 - 32
  • [29] cDNA cloning and tissue distribution of the rat ortholog of tissue factor pathway inhibitor-2
    Hisaka, T
    Kisiel, W
    Rosenbaum, J
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (02) : 356 - 357
  • [30] Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma
    Xu, Yong
    Qin, Xiaolin
    Zhou, Jinjing
    Tu, Zhiguang
    Bi, Xiao
    Li, Wuxian
    Fan, Xiaoqing
    Zhang, Yi
    ONCOLOGY LETTERS, 2011, 2 (05) : 779 - 783
12345